MAR002 not checked

Marea Therapeutics

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Acromegaly (2 trials)
Main trialPhase 2
“Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in participants with acromegaly”In the company’s words, NCT07641179 on ClinicalTrials.gov

Other drugs for Acromegaly

All 2 drugs for Acromegaly

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Aug 2027 A Study to Evaluate MAR002 for Acromegaly
Phase 1Recruiting Jul 2026 Study of MAR002 in Healthy Men
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow MAR002

Following is part of Solo: you see every change to MAR002 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in